Compositions and methods for treatment of rosacea

Details for Australian Patent Application No. 2004251710 (hide)

Owner ProCyte Corporation

Inventors Patt, Leonard M.

Agent Davies Collison Cave

Pub. Number AU-A-2004251710

PCT Pub. Number WO2005/000337

Priority 10/457,045 06.06.03 US

Filing date 6 June 2004

Wipo publication date 6 January 2005

International Classifications

A61K 38/04 (2006.01) Medicinal preparations containing peptides - Peptides having up to 20 amino acids in a fully defined sequence

C07F 1/08 (2006.01) Compounds containing elements of the 1st Group of the Periodic System

A61P 17/10 (2006.01) Drugs for dermatological disorders

A61K 33/34 (2006.01) Medicinal preparations containing inorganic active ingredients - Copper

A61P 17/00 (2006.01) Drugs for dermatological disorders

C07K 5/08 (2006.01) Peptides having up to four amino acids in a fully defined sequence

Event Publications

15 December 2005 PCT application entered the National Phase

  PCT publication WO2005/000337 Priority application(s): WO2005/000337

3 April 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004251712-Novel therapeautic agents for the treatment of cancer, metabolic diseases and skin disorders

2004251708-Use of a clostridial toxin to reduce appetite